EVASC-NEUROVASCULAR
23.2.2021 07:31:12 CET | Business Wire | Press release
Evasc Neurovascular is proud to announce its successful application to France’s Ministry of Health (Haute Autorité de la Santé, HAS) Forfait Innovation (FI) program for the eCLIPs™ device, published in its official journal December 23, 2020 - https://www.legifrance.gouv.fr/jorf/id/JORFTEXT000042722732 .
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20210222005015/en/
The Forfait Innovation program grants clinical trial funding to evaluate CE marked devices that are deemed to be truly innovative (not simply incremental developments) and offer significant clinical benefit, filling an unmet medical need. The eCLIPs device is the first neuro device that has gained FI approval and funding. The funded amount of €2.76 million covers hospital costs of a 119-patient trial against optimal performance criteria (OPC).
Dr. Donald Ricci, CEO of Evasc Neurovascular, comments, “We are pleased to have confirmation by an influential and independent third party, the French Ministry of Health, that eCLIPs represents an innovation in the treatment of intracranial bifurcation aneurysms, a consistent message in our presentations, publications and discussions with neuro-interventionalists over the past few years.”
About the eCLIPs Aneurysm Treatment System
eCLIPs is a non-tubular endovascular device currently targeted for use in challenging wide-neck bifurcations, using technology designed to treat 95% of cerebral aneurysm cases. The unique eCLIPs design provides not only coil retention, but also flow diversion at the neck. eCLIPs avoids dangerous entry into the dynamic, fragile environment of the aneurysm sac while leaving side branches unencumbered and providing a platform for endothelial growth across the bifurcation neck.
About Evasc Neurovascular
Evasc Neurovascular is a privately-held medical device company focused on the development of disruptive endovascular treatments for cerebral aneurysms. Evasc Neurovascluar is headquartered in Vancouver, Canada.
Visit Evasc Neurovascular at www.evasc.com .
View source version on businesswire.com: https://www.businesswire.com/news/home/20210222005015/en/
Link:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
92% of Compliance Leaders Want External Certification on AI Agents. None Exists for On-Chain Risk. Elliptic Just Built It, for Free.20.10.2026 16:00:00 CEST | Press release
Elliptic Institute launches the first certification in agentic AI for on-chain risk and compliance, grounded in the principles of the Elliptic Standard. Elliptic, the leader in on-chain risk management, today launched the first certification in governing AI agents for on-chain risk and financial crime compliance from the Elliptic Institute. The Certified Agentic On-Chain Risk Practitioner (CAORP) Foundation Level is free and open to anyone in the industry. The certification follows new Elliptic research in which 92% of senior risk, compliance and financial crime professionals said they would consider sending staff for external certification in agentic AI risk governance. The global research1 found a wide gap between that appetite and teams' current capability. Only 16% of respondents said they were very confident their team has the skills to govern an AI agent today, while 38% said they were not confident at all or had no capability yet. Nearly a third (31%) expect to send staff for ce
Xceedance Named a Leader and Star Performer in Everest Group’s Insurance Intermediaries Operations PEAK Matrix® Assessment 202620.10.2026 16:00:00 CEST | Press release
Assessment highlights Xceedance’s MGA capabilities, strategic acquisitions, and intermediary-focused technology ecosystem Xceedance today announced it has been named a Leader and Star Performer in the Everest Group Insurance Intermediaries Operations PEAK Matrix® Assessment 2026. The assessment evaluated 18 providers based on market impact and their vision and capability to deliver insurance intermediary operations services. Everest Group identified Xceedance’s support for MGAs and MGUs across entity setup and licensing, underwriting, policy administration, finance, analytics, and claims as a key strength. The report also highlighted enabling rapid program launches and scaling through a licensed MGA shell, configurable workflows, and integrated operations. “Xceedance brings deep insurance expertise and a growing breadth of capabilities to support MGAs, brokers, and Lloyd’s market participants,” said Dinesh Udawat, Practice Director, Everest Group. “Its strategic acquisitions have expan
International AI Strategist and Author Katie King to Keynote IAMPHENOM Europe 202620.10.2026 15:30:00 CEST | Press release
Practitioner-led agenda shows Europe’s CHROs, talent leaders and HRIT teams how to redesign work with AI, agents and automation Phenom, the leader in applied AI built to redesign work operations for hiring faster, developing better and retaining longer, announced Katie King, an internationally recognised AI strategist, author and adviser on the future of work, as a keynote speaker at IAMPHENOM Europe 2026, taking place 4-5 November in Paris, France. Phenom also unveiled the conference agenda, which centres on the decisions European HR leaders face right now: turning AI, agents and automation into business outcomes, deploying tech with a compliant-first approach, and redesigning roles and skills for the future workforce. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261020028392/en/ Phenom announced Katie King, an internationally recognised AI strategist, author and adviser on the future of work, as a keynote speaker at IAMP
Inaugural Future Health Impact Challenge Documentary Released as Expressions of Interest Open for Second Challenge20.10.2026 15:26:00 CEST | Press release
Documentary follows ThinkMD, VectorCam, and Huna, the three award recipients from the inaugural Future Health Impact Challenge, delivered in collaboration with MIT Solve Prospective participants can now register to receive information about the second Future Health Impact Challenge ahead of its upcoming full launch Future Health – A Global Initiative by Abu Dhabi today premiered a documentary film about the inaugural Future Health Impact Challenge during the first day of the Abu Dhabi Future Health Summit. The film’s global launch, alongside the announcement of the second Challenge connects the Challenge’s initial results with its next phase with Expressions of Interest now open for the second edition. Delivered in collaboration with MIT Solve, the inaugural Impact Challenge demonstrates the transformative power of innovative solutions that accelerate the shift from reactive to anticipatory healthcare systems. With scenes filmed in Kigali, Medellín, São Paulo, Boston, and Abu Dhabi, th
WETEX 2026 attracts 60 sponsoring institutions and companies from the UAE and abroad20.10.2026 15:19:00 CEST | Press release
Dubai Electricity and Water Authority (DEWA) is organising the 28th edition of the Water, Energy, Technology and Environment Exhibition (WETEX) from 20 to 22 October 2026 at the Dubai World Trade Centre. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261020867659/en/ WETEX 2026 attracts 60 sponsoring institutions and companies from the UAE and abroad (Graphic: AETOSWire) “WETEX reflects the forward-looking vision of His Highness Sheikh Mohamed bin Zayed Al Nahyan, President of the UAE, and His Highness Sheikh Mohammed bin Rashid Al Maktoum, Vice President and Prime Minister of the UAE and Ruler of Dubai, to leverage innovation and advanced global technologies, including digital transformation, artificial intelligence (AI) and smart infrastructure, to strengthen the sustainability and resilience of the water and energy sectors while encouraging climate action,” said HE Saeed Mohammed Al Tayer, MD & CEO of DEWA and Founder and
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom